These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31722750)

  • 1. Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis.
    Wang YQ; Zhang Y; Jiang W; Chen YP; Xu SY; Liu N; Zhao Y; Li L; Lei Y; Hong XH; Liang YL; Li JY; Zhang LL; Yun JP; Sun Y; Li YQ; Ma J
    J Immunother Cancer; 2019 Nov; 7(1):298. PubMed ID: 31722750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression Profiles and Prognostic Value of Multiple Inhibitory Checkpoints in Head and Neck Lymphoepithelioma-Like Carcinoma.
    Zou WQ; Luo WJ; Feng YF; Liu F; Liang SB; Fang XL; Liang YL; Liu N; Wang YQ; Mao YP
    Front Immunol; 2022; 13():818411. PubMed ID: 35140722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Immune Checkpoint Regulators, Cytotoxic T-Lymphocyte Antigen-4, and Programmed Death-Ligand 1 in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.
    Ahmed MM; Gebriel MG; Morad EA; Saber IM; Elwan A; Salah M; Fakhr AE; Shalaby AM; Alabiad MA
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):401-408. PubMed ID: 33480605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma.
    Zeng L; Xu H; Li SH; Xu SY; Chen K; Qin LJ; Miao L; Wang F; Deng L; Wang FH; Li L; Fu S; Liu N; Wang R; Li YQ; Wang HY
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37130627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Infiltration of ICOS
    Zhang G; Xu Y; Zhou H
    Pathol Oncol Res; 2020 Jan; 26(1):365-370. PubMed ID: 30361907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer.
    Mitchell KG; Parra ER; Nelson DB; Zhang J; Wistuba II; Fujimoto J; Roth JA; Antonoff MB;
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):911-919.e6. PubMed ID: 31235357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma.
    Kim AK; Gani F; Layman AJ; Besharati S; Zhu Q; Succaria F; Engle EL; Bhaijee F; Goggins MB; Llosa NJ; Pawlik TM; Yarchoan M; Jaffee EM; Simons HC; Taube JM; Anders RA
    Cancer Immunol Res; 2019 May; 7(5):805-812. PubMed ID: 30902819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of B7 family checkpoint proteins in cervical cancer.
    Zong L; Gu Y; Zhou Y; Kong Y; Mo S; Yu S; Xiang Y; Chen J
    Mod Pathol; 2022 Jun; 35(6):786-793. PubMed ID: 34848831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors.
    Parra ER; Villalobos P; Zhang J; Behrens C; Mino B; Swisher S; Sepesi B; Weissferdt A; Kalhor N; Heymach JV; Moran C; Zhang J; Lee J; Rodriguez-Canales J; Gibbons D; Wistuba II
    J Thorac Oncol; 2018 Jun; 13(6):779-791. PubMed ID: 29526824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.
    Lai C; Zhang C; Lv H; Huang H; Ke X; Zhou C; Chen H; Chen S; Zhou L
    Cancer Med; 2021 Jun; 10(11):3511-3523. PubMed ID: 33973727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of CXCL1
    Wen YF; Huang WJ; Chen XL; Cai HT; Zhang YB; Song XL; Xie CB; Peng HH; Yu HW; Chen CC; Wei LQ; Zhou TC; Cai S; Wang F; Lin XD
    Oral Oncol; 2024 Oct; 157():106963. PubMed ID: 39032343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma.
    Chen X; Ma H; Mo S; Zhang Y; Lu Z; Yu S; Chen J
    Front Immunol; 2022; 13():942154. PubMed ID: 35936015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer.
    Zong L; Zhou Y; Zhang M; Chen J; Xiang Y
    Cancer Immunol Immunother; 2020 Jan; 69(1):33-42. PubMed ID: 31781843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good prognostic factor in patients with nonmetastatic nasopharyngeal carcinoma: Programmed death ligand-1 expression in tumor cells.
    Sahinli H; Akyürek N; Yılmaz M; Kandemir O; Duran AO; Kulaçoǧlu S; Uçar G; Acar E; Özet A; Öksüzoǧlu OBÇ; Özdemir NY
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S43-S47. PubMed ID: 33380650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of novel immune-checkpoint targets in ovarian cancer tumor microenvironment: A dynamic landscape.
    Blanc-Durand F; Genestie C; Galende EY; Gouy S; Morice P; Pautier P; Maulard A; Mesnage S; Le Formal A; Brizais C; Richardson M; Leary A
    Gynecol Oncol; 2021 Jan; 160(1):279-284. PubMed ID: 33162175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
    Fukuda T; Kamai T; Masuda A; Nukui A; Abe H; Arai K; Yoshida K
    Cancer Med; 2016 Aug; 5(8):1810-20. PubMed ID: 27292320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis significance of indoleamine 2, 3-dioxygenase, programmed death ligand-1 and tumor-infiltrating immune cells in microenvironment of breast cancer.
    Wei L; Wu N; Wei F; Li F; Zhang Y; Liu J; Ren X
    Int Immunopharmacol; 2020 Jul; 84():106506. PubMed ID: 32330866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second- and third-generation drugs for immuno-oncology treatment-The more the better?
    Dempke WCM; Fenchel K; Uciechowski P; Dale SP
    Eur J Cancer; 2017 Mar; 74():55-72. PubMed ID: 28335888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.